• Founder and CEO of STRATCON (Strategy Consulting For Health Care Executives), Nuremberg, Germany
  • Former CEO of Sandoz AG, Nuremberg, Germany
  • Active member of several strategic committees in pharmaceutical industry

Joerg Ruppert, PhD, Vice-Chairman

  • Investment manager of Heidelberg Innovation, Heidelberg, Germany
  • Board member of several German biotech companies/li>
  • Director of Marketing at ICN Biomedicals, Meckenheim/Eschwege, Germany

Prof. Ernst-Günter Afting, MD, PhD

  • President of “GSF-Forschungszentrum für Umwelt und Gesundheit”, the German National Research Center for Environment and Health, Munich, Germany
  • Former President of worldwide Pharma Research, Hoechst AG, Frankfurt, Germany
  • Former President and CEO of Roussel UCLAF (Hoechst) and the Pharma Division of Hoechst AG

Prof. Horst Domdey, PhD

  • CEO of BioM AG, Martinsried, Germany
  • Managing Director of the Innovation Center for Biotechnology, Martinsried, Germany
  • Co-founder of various biotech companies

John Kim, MD, MBA

  • Managing Director of Burrill & Co, San Francisco, USA /li>
  • Former equity research analyst at Goldman Sachs
  • MBA with Distinction from Wharton School (University of Pennsylvania)

Sven Rohmann, MD, PhD

  • CEO of BioVisioN AG, Hannover, Germany
  • Former Global Head Strategic Marketing Oncology, Merck KGaA, Darmstadt, Germany